ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design
Makaleler > Tam Makale · 2017
Yazarlar: Richard Češka, György Paragh, Željko Reiner, Maciej Banach, Lale Tokgözoğlu, Andrey V. Susekov, Katarína Rašlová, Tomáš Freiberger, Branislav Vohnout, Andrzej Rynkiewicz, Assen Goudev, Dan Gheorghe-Andrei, Dan Gaiţă, Belma Pojskić, Ivan Pećin, Latife Meral KAYIKÇIOĞLU, Olena Mitchenko, Marat V. Ezhov, Gustavs Latkovskis, Žaneta Petrulionienė, Zlatko Fras, Nebojsa Tasić, Erkin M. Mirrakhimov, Tolkun Murataliev, Alexander B. Shek, Vladimír Tuka, Alexandros D. Tselepis, Elie M. Moubarak, Khalid Al Rasadi
Vnitřní lékařství, Uluslararası, Scopus, 2017, cilt 63, ss 43-48
Özet
Familial hypercholesterolemia (FH) is a genetic disorder with well-known genetic transmission and clinical course. Despite great recent progress, FH is still underestimated, under-diagnosed and thus undertreated. Furthermore it represents a significant healthcare challenge as a common risk factor for the premature development of coronary heart disease. The ScreenPro FH Project is an international network project aiming at improving complex care - from timely screening, through diagnosis to up-to-date treatment of familial hypercholesterolemia in Central, Eastern and Southern Europe. An important task for the project is to harmonise and unify diagnostic and therapeutic approaches in participating countries, where the situation differs from country to country. Countries with more experience should serve as a model for countries developing the FH network.Key words: diagnosis - familial hypercholesterolemia - screening - treatment optimization.